Influence of the lactotripeptides isoleucine-proline-proline and valine-proline-proline on systolic blood pressure in Japanese subjects: A systematic review and meta-analysis of randomized controlled trials

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Chanson Rolle, Aurelie ^a   Aubin, François ^b   Braesco, Veronique ^a   Hamasaki, Toshimitsu ^c   Kitakaze, Masafumi ^c  

^a VAB nutrition   (France)

^b Venn Life Sciences   (France)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ISOLEUCYLPROLYLPROLINE LACTOTRIPEPTIDE; PLACEBO; TRIPEPTIDE DERIVATIVE; UNCLASSIFIED DRUG; VALYLPROLYLPROLINE LACTOTRIPEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ISOLEUCYL-PROLYL-PROLINE; OLIGOPEPTIDE; VALYL-PROLYL-PROLINE;

AGE DISTRIBUTION; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; EFFECT SIZE; HUMAN; HYPERTENSION; JAPANESE (PEOPLE); META ANALYSIS; OUTCOME ASSESSMENT; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; ADULT; BLOOD PRESSURE; DRUG EFFECTS; JAPAN; MIDDLE AGED;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PRESSURE; HUMANS; HYPERTENSION; JAPAN; MIDDLE AGED; OLIGOPEPTIDES; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84951066598     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0142235     Document Type: Article

References (46)

1. Nakamura K, Okamura T, Miura K, Okayama A. Hypertension and medical expenditure in the Japanese population: Review of prospective studies. World journal of cardiology. 2014; 6 (7): 531-8. doi: 10. 4330/wjc.v6.i7.531 PMID: 25068014
2. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003; 42 (6): 1206-52. PMID: 14656957
3. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Journal of hypertension. 2013; 31 (7): 1281-357. doi: 10.1097/01.hjh.0000431740.32696.cc PMID: 23817082
4. Cicero AF, Gerocarni B, Laghi L, Borghi C. Blood pressure lowering effect of lactotripeptides assumed as functional foods: a meta-analysis of current available clinical trials. Journal of human hypertension. 2011; 25 (7): 425-36. doi: 10.1038/jhh.2010.85 PMID: 20811398
5. Pripp AH. Effect of peptides derived from food proteins on blood pressure: a meta-analysis of randomized controlled trials. Food & nutrition research. 2008; 52. doi: 10.3402/fnr.v52i0.1641 PMID: 19109662
6. Xu JY, Qin LQ, Wang PY, Li W, Chang C. Effect of milk tripeptides on blood pressure: a meta-analysis of randomized controlled trials. Nutrition (Burbank, Los Angeles County, Calif). 2008; 24 (10): 933-40.
7. Nakamura Y, Yamamoto N, Sakai K, Okubo A, Yamazaki S, Takano T. Purification and characterization of angiotensin I-converting enzyme inhibitors from sour milk. Journal of dairy science. 1995; 78 (4): 777-83. PMID: 7790570
8. Masuda O, Nakamura Y, Takano T. Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. The Journal of nutrition. 1996; 126 (12): 3063-8. PMID: 9001375
9. Nakamura Y, Yamamoto N, Sakai K, Takano T. Antihypertensive effect of sour milk and peptides isolated from it that are inhibitors to angiotensin I-converting enzyme. Journal of dairy science. 1995; 78 (6): 1253-7. PMID: 7673515
10. Pina AS, Roque AC. Studies on the molecular recognition between bioactive peptides and angiotensinconverting enzyme. Journal of molecular recognition: JMR. 2009; 22 (2): 162-8. doi: 10.1002/jmr.905 PMID: 18816584
11. Hirota T, Nonaka A, Matsushita A, Uchida N, Ohki K, Asakura M, et al. Milk casein-derived tripeptides, VPP and IPP induced NO production in cultured endothelial cells and endothelium-dependent relaxation of isolated aortic rings. Heart and vessels. 2011; 26 (5): 549-56. doi: 10.1007/s00380-010-0096-y PMID: 21221598
12. Yamaguchi N, Kawaguchi K, Yamamoto N. Study of the mechanism of antihypertensive peptides VPP and IPP in spontaneously hypertensive rats by DNA microarray analysis. European journal of pharmacology. 2009; 620 (1-3): 71-7. doi: 10.1016/j.ejphar.2009.08.005 PMID: 19686729
13. Usinger L, Ibsen H, Linneberg A, Azizi M, Flambard B, Jensen LT. Human in vivo study of the reninangiotensin-aldosterone system and the sympathetic activity after 8 weeks daily intake of fermented milk. Clinical physiology and functional imaging. 2010; 30 (2): 162-8. doi: 10.1111/j.1475-097X.2009. 00921.x PMID: 20113315
14. Fekete AA, Givens DI, Lovegrove JA. Casein-derived lactotripeptides reduce systolic and diastolic blood pressure in a meta-analysis of randomised clinical trials. Nutrients. 2015; 7 (1): 659-81. doi: 10. 3390/nu7010659 PMID: 25608938
15. Cicero AF, Aubin F, Azais-Braesco V, Borghi C. Do the lactotripeptides isoleucine-proline-proline and valine-proline-proline reduce systolic blood pressure in European subjects? A meta-analysis of randomized controlled trials. American journal of hypertension. 2013; 26 (3): 442-9. doi: 10.1093/ajh/ hps044 PMID: 23382495
16. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (Clinical research ed). 2009; 339: b2700.
17. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Controlled Clinical Trials. 1996; 17 (1): 1-12. PMID: 8721797
18. Sutton A, Abrams K, Jones D, Sheldon T, Song F. Methods for Meta-Analysis in Medical Research. Chichester: John Wiley & Sons; 2000.
19. Viechtbauer W. Conducting Meta-Analyses in R with the metafor Package. Journal of Statistical Software. 2010; 36 (3): 1-48.
20. Cochran W. The combination of estimates from different experiments. Biometrics 1954; 10: 101-29.
21. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50 (4): 1088-101. PMID: 7786990
22. Aihara K, Kajimoto O, Hirata H, Takahashi R, Nakamura Y. Effect of powdered fermented milk with Lactobacillus helveticus on subjects with high-normal blood pressure or mild hypertension. Journal of the American College of Nutrition. 2005; 24 (4): 257-65. PMID: 16093403
23. Ishida Y, Aihara K, Sagitani A, Kaneko K, Mizutani J, Nakamura K, et al. [Safety Evaluation of Excessive Intake of the Tablet Containing "Lactotripeptides (VPP, IPP)" in Subjects with Normal Blood Pressure to Mild Hypertension]. JapanesePharmacology & Therapeutics. 2006; 34: 1107-17. Japanese.
24. Ishida Y, Sagitani A, Kaneko K, Nakamura Y, Mizutani J, Masuda O. [Antihypertensive Effects of the Tablet Containing "Lactotripeptide (VPP, IPP)" in Subjects with High Normal Blood Pressure to Mild Hypertension]. Japanese Pharmacology & Therapeutics. 2007; 35 (12): 1249-60. Japanese.
25. Ishida Y, Shibata Y, Fukuhara I, Yano Y, Takehara I, Kaneko K. Effect of an excess intake of casein hydrolysate containing Val-Pro-Pro and Ile-Pro-Pro in subjects with normal blood pressure, high-normal blood pressure, or mild hypertension. Bioscience, biotechnology, and biochemistry. 2011; 75 (3): 427-33. PMID: 21389626
26. Itakura H, Ikemoto S, Terada S, Kondo K. [The Effect of Sour Milk on Blood Pressure in Untreated Hypertensive and Normotensive Subjects]. Journal of Japanese Society of Clinical Nutrition. 2001; 23 (3): 26-31. Japanese.
27. Kajimoto O, Aihara K, Hirata H, Takahashi R, Nakamura Y. [Hypotensive Effects of The Tablets Containing "Lactotripeptides (VPP, IPP)"]. Journal of Nutritional Food. 2001; 4 (3): 51-61. Japanese.
28. Kajimoto O, Aihara K, Hirata H, Takahashi R, Nakamura Y. [Safety evaluation of excessive intake of the tablet containing "Lactotripeptides (VPP, IPP)" on healthy volunteers]. Journal of Nutritional Food. 2001; 4 (4): 37-46. Japanese.
29. Kajimoto O, Ishida Y, Nakamura Y, Sagitani A, Masuda O. [Exploratory study on the efficacy of tablet containing lactotripeptides (VPP, IPP) for patients with mild hypertension]. Journal New Rem & Clin. 2007; 56 (12): 129-37. Japanese.
30. Kajimoto O, Kurosaki T, Mizutani J, Ikeda N, Kaneko K, Aihara K, et al. [Antihypertensive effects of liquid yogurts containing "lactotripeptides (VPP, IPP)" in mild hypertensive subjects]. Journal of Nutritional Food. 2002; 5 (3): 55-66. Japanese.
31. Kajimoto O, Nakamura Y, Yada H, Moriguchi S, Hirata H, Takahashi T. [Hypotensive Effects of Sour Milk in Subjects with Mild or Moderate Hypertension]. Journal of Japanese Society for Nutrition and Food Science. 2001; 54: 347-54. Japanese.
32. Mizuno S, Matsuura K, Gotou T, Nishimura S, Kajimoto O, Yabune M, et al. Antihypertensive effect of casein hydrolysate in a placebo-controlled study in subjects with high-normal blood pressure and mild hypertension. The British journal of nutrition. 2005; 94 (1): 84-91. PMID: 16115337
33. Mizushima S, Ohshige K, Watanabe J, Kimura M, Kadowaki T, Nakamura Y, et al. Randomized controlled trial of sour milk on blood pressure in borderline hypertensive men. American journal of hypertension. 2004; 17 (8): 701-6. PMID: 15288885
34. Nakamura T, Mizutani J, Ohki K, Yamada K, Yamamoto N, Takeshi M, et al. Casein hydrolysate containing Val-Pro-Pro and Ile-Pro-Pro improves central blood pressure and arterial stiffness in hypertensive subjects: a randomized, double-blind, placebo-controlled trial. Atherosclerosis. 2011; 219 (1): 298-303. doi: 10.1016/j.atherosclerosis.2011.06.007 PMID: 21723554
35. Nakamura Y, Kajimoto O, Kaneko K, Aihara K, Mizutani J, Ikeda N, et al. [Effects of the liquid yogurts containing "lactotripeptide (VPP, IPP)" on high-normal blood pressure]. Journal of Nutritional Food. 2004; 7 (1): 123-37. Japanese.
36. Sano J, Higuchi T, Aihara K, Mizuno S, Kajimoto O, Nakagawa S, et al. [Safety evaluation of excessive intake of drink containing "lactotripeptides (VPP, IPP)" in subjects with normal blood pressure to mild hypertension]. Journal of Nutritional Food. 2004; 7 (4): 17-30. Japanese.
37. Sano J, Ohki K, Higuchi T, Aihara K, Mizuno S, Kajimoto O, et al. Effect of casein hydrolysate, prepared with protease derived from Aspergillus oryzae, on subjects with high-normal blood pressure or mild hypertension. Journal of medicinal food. 2005; 8 (4): 423-30. PMID: 16379551
38. Yoshizawa M, Maeda S, Miyaki A, Misono M, Choi Y, Shimojo N, et al. Additive beneficial effects of lactotripeptides intake with regular exercise on endothelium-dependent dilatation in postmenopausal women. American journal of hypertension. 2010; 23 (4): 368-72. doi: 10.1038/ajh.2009.270 PMID: 20075849
39. Hirata H, Nakamura Y, Yada H, Moriguchi S, Kajimoto O, Takahashi T. [Clinical Effects of New Sour Milk Drink on Mild or Moderate Hypertensive Subjects]. Journal New Rem & Clin. 2002; 51 (1): 61-9. Japanese.
40. Lawes CM, Rodgers A, Bennett DA, Parag V, Suh I, Ueshima H, et al. Blood pressure and cardiovascular disease in the Asia Pacific region. Journal of hypertension. 2003; 21 (4): 707-16. PMID: 12658016
41. Murakami Y, Hozawa A, Okamura T, Ueshima H, Group tEfCPFOCiJR. Relation of Blood Pressure and All-Cause Mortality in 180 000 Japanese Participants: Pooled Analysis of 13 Cohort Studies. Hypertension. 2008; 51 (6): 1483-91. doi: 10.1161/HYPERTENSIONAHA.107.102459 PMID: 18443234
42. He FJ, MacGregor GA. Effect of longer-term modest salt reduction on blood pressure. The Cochrane database of systematic reviews. 2004 (3): CD004937. PMID: 15266549
43. Jurgens G, Graudal NA. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride. The Cochrane database of systematic reviews. 2003 (1): CD004022. PMID: 12535503
44. Ueshima H, Ogihara T, Baba S, Tabuchi Y, Mikawa K, Hashizume K, et al. The effect of reduced alcohol consumption on blood pressure: a randomised, controlled, single blind study. Journal of human hypertension. 1987; 1 (2): 113-9. PMID: 3333522
45. van der Zander K, Bots ML, Bak AA, Koning MM, de Leeuw PW. Enzymatically hydrolyzed lactotripeptides do not lower blood pressure in mildly hypertensive subjects. The American journal of clinical nutrition. 2008; 88 (6): 1697-702. doi: 10.3945/ajcn.2008.26003 PMID: 19064533
46. Messerli FH, Williams B, Ritz E. Essential hypertension. Lancet. 2007; 370 (9587): 591-603. PMID: 17707755